Tsukuba, Japan

Seiji Kaku

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Yamanouchi Pharmaceutical Company Ltd., Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1998-2000.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Ibaraki, JP (1998)
  • Shizuoka, JP (1999)
  • Tsukuba, JP (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Seiji Kaku: Innovator in Medicinal Chemistry

Introduction

Seiji Kaku is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of medicinal chemistry, holding a total of three patents. His work focuses on the development of novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are "Substituted amidinobenzene derivatives and medicinal compositions thereof," "Amidinonaphthyl derivative or salt thereof," and other innovative compounds. These patents reflect his dedication to advancing medicinal chemistry and improving healthcare solutions.

Career Highlights

Seiji Kaku has had a distinguished career, working with notable companies such as Yamanouchi Pharmaceutical Company Ltd. and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Throughout his career, Kaku has collaborated with esteemed colleagues, including Yuzo Matsumoto and Tomihisa Kawasaki. These partnerships have fostered a collaborative environment that enhances innovation and research in medicinal chemistry.

Conclusion

Seiji Kaku's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to inspire advancements in healthcare and pharmaceutical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…